Delivery Order SPE2DR25D1100-SPE2DR26FCK2U
- Not listed
- The Defense Logistics Agency awarded a $1,162.17 delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of October 16, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,549.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Corlanor 5 mg tablets (60-count). This is a non-set-aside contract with an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,457.28 for Corlanor 5 mg tablets (60-count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Corlanor 5 mg tablets (60-count unit) valued at $4,410.48 under a firm fixed-price contract type. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $30.4K delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 29, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a direct purchase under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,555.55 on September 24, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Corlanor 5 mg tablets (60-count units) with a contract ceiling value of $22,080.66. This non-set-aside, competitively awarded delivery order employs firm fixed pricing and is scheduled for completion by September 15, 2025. The contract represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical vendor for federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $4,484.78. This firm fixed-price delivery order is scheduled for completion by September 19, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Corlanor 5 mg tablets (60-count units) with a ceiling value of $7,155.48 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award involved...
- The Defense Logistics Agency awarded a $9,479.97 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCK2UDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Corlanor 5 mg tablets (60-count) valued at $5,060.71. This firm fixed-price delivery order, with an ultimate completion date of October 24, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the DLA. The award was made through open competition with no set-aside designation, and performance will be executed from the company's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement requirements across diverse therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 10/23/25 |